Cargando…

Signature of Alzheimer’s Disease in Intestinal Microbiome: Results From the AlzBiom Study

BACKGROUND: Changes in intestinal microbiome composition have been described in animal models of Alzheimer’s disease (AD) and AD patients. Here we investigated how well taxonomic and functional intestinal microbiome data and their combination with clinical data can be used to discriminate between am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laske, Christoph, Müller, Stephan, Preische, Oliver, Ruschil, Victoria, Munk, Matthias H. J., Honold, Iris, Peter, Silke, Schoppmeier, Ulrich, Willmann, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063165/ https://www.ncbi.nlm.nih.gov/pubmed/35516807 http://dx.doi.org/10.3389/fnins.2022.792996

Ejemplares similares

Increased Diagnostic Accuracy of Digital vs. Conventional Clock Drawing Test for Discrimination of Patients in the Early Course of Alzheimer’s Disease from Cognitively Healthy Individuals
por: Müller, Stephan, et al.
Publicado: (2017)

AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
por: Mizuno, Satoshi, et al.
Publicado: (2012)

Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer’s disease from healthy individuals
por: Müller, Stephan, et al.
Publicado: (2019)

AlzPlatform: An Alzheimer’s Disease Domain-Specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research
por: Liu, Haibin, et al.
Publicado: (2014)

AlzPharm: integration of neurodegeneration data using RDF
por: Lam, Hugo YK, et al.
Publicado: (2007)

Transcriptomic Basis of Serum Resistance and Virulence Related Traits in XDR P. aeruginosa Evolved Under Antibiotic Pressure in a Morbidostat Device
por: Javed, Mumina, et al.
Publicado: (2021)

Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease
por: Hey, John A., et al.
Publicado: (2017)

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials
por: Wessels, Alette M., et al.
Publicado: (2020)

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discovery
por: Zhou, Yadi, et al.
Publicado: (2021)

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
por: Sandberg, Anders, et al.
Publicado: (2022)

Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings
por: Wessels, Alette M., et al.
Publicado: (2023)

CAD-ALZ: A Blockwise Fine-Tuning Strategy on Convolutional Model and Random Forest Classifier for Recognition of Multistage Alzheimer’s Disease
por: Abbas, Qaisar, et al.
Publicado: (2023)

TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease
por: Salloway, Stephen, et al.
Publicado: (2023)

Meta Analysis of Human AlzGene Database: Benefits and Limitations of Using C. elegans for the Study of Alzheimer's Disease and Co-morbid Conditions
por: Vahdati Nia, Behrad, et al.
Publicado: (2017)

Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
por: Tolar, Martin, et al.
Publicado: (2020)

Microbiome Yarns: human biome reproduction, evolution and visual acuity,,,
por: Timmis, Kenneth, et al.
Publicado: (2017)

BiomMiner: An advanced exploratory microbiome analysis and visualization pipeline
por: Shamsaddini, Amirhossein, et al.
Publicado: (2020)

BiomeHorizon: Visualizing Microbiome Time Series Data in R
por: Fink, Isaac, et al.
Publicado: (2022)

The effect of single biome occupancy on the estimation of biome shifts and the detection of biome conservatism
por: Dale, Esther E., et al.
Publicado: (2021)

The clinical use of blood-test factors for Alzheimer’s disease: improving the prediction of cerebral amyloid deposition by the QPLEX(TM)Alz plus assay kit
por: Kim, Haeng Jun, et al.
Publicado: (2021)

Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial
por: Pontecorvo, Michael J., et al.
Publicado: (2022)

The microbiome shifts throughout the gastrointestinal tract of Bradford cattle in the Pampa biome
por: de Freitas, Anderson Santos, et al.
Publicado: (2022)

Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition
por: Park, Jong-Chan, et al.
Publicado: (2021)

A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD
por: McNett, Sienna D., et al.
Publicado: (2023)

EMBED: Essential MicroBiomE Dynamics, a dimensionality reduction approach for longitudinal microbiome studies
por: Shahin, Mayar, et al.
Publicado: (2023)

Translational metagenomics and the human resistome: confronting the menace of the new millennium
por: Willmann, Matthias, et al.
Publicado: (2016)

Biome engineering‐2020
por: Brüssow, Harald
Publicado: (2016)

AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353 157 patients in London, UK
por: Wagner, Siegfried Karl, et al.
Publicado: (2022)

Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial
por: Shcherbinin, Sergey, et al.
Publicado: (2022)

Microbiome yarns: The Global Phenotype‐Genotype Survey. Episode III: importance of microbiota diversification for microbiome function and biome health
por: Timmis, Kenneth, et al.
Publicado: (2019)

Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain
por: Hey, John A., et al.
Publicado: (2018)

Polioencephalomalacia in Buffaloes in the Amazon Biome
por: Barbosa, José Diomedes, et al.
Publicado: (2023)

In Vitro Evaluation of Probiotic Properties of Two Novel Probiotic Mixtures, Consti-Biome and Sensi-Biome
por: Jang, You Jin, et al.
Publicado: (2023)

New species and illustrated key of Macraspis (Scarabaeidae, Rutelinae, Rutelini) from the Amazon biome of Brazil
por: Bento, Matheus, et al.
Publicado: (2022)

Acceptability and feasibility of fecal microBIOME and serum metabolite sample collection in people with end-stage kidney disease and pain being treated with HemoDialysis: A pilot study (BIOME-HDp)
por: Lockwood, Mark B., et al.
Publicado: (2022)

Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study
por: Willmann, Matthias, et al.
Publicado: (2019)

Whole-body modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer’s disease
por: Martinelli, Filippo, et al.
Publicado: (2023)

R4Alz-Revised: A Tool Able to Strongly Discriminate ‘Subjective Cognitive Decline’ from Healthy Cognition and ‘Minor Neurocognitive Disorder’
por: Poptsi, Eleni, et al.
Publicado: (2023)

BioMe: biologically relevant metals
por: Tus, Alan, et al.
Publicado: (2012)

Introduction to the BIOMED 2012 Feature Issue
por: Pogue, Brian W., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h722ta4psb44sr6q3ge3h3ha8v